Josh Simon, PhD, Business Development Manager at Secant Medical, will be giving a presentation at the BioInterface 2013 Annual Conference in Minneapolis, to demonstrate Secant Medical's commitment to biomaterials research and development.

Dr Simon will discuss matching third-generation biomaterials with textile engineering to create structures that repair, recover and regenerate the body at the event’s Applied Technology Workshops on 7 October.

“At Secant Medical, the end goal is to facilitate the creation of structures that improve the long-term chronic biologic response by reducing inflammation, preventing secondary procedures, and enabling the body to regenerate on its own,” said Dr Simon.

New biomaterials

During his presentation Dr Simon will touch on the customisable properties, platforms and regenerative medicine applications of a new bioelastomer, being developed by Secant Medical.

He will also explain how the company’s focus on biomaterials and expertise in textile engineering can lead to the creation of regenerative structures for surgical mesh, heart valves, tendons and ligament repair, and nerve regeneration.

“This generation of new biomaterials presents a value proposition that cannot be ignored in today’s healthcare environment, and I am excited to share what our company is developing in this area.”

BioInterface 2013

The BioInterface 2013 annual conference is an event held by the Surfaces in Biomaterials Foundation to connect, share and learn about the field of biomaterial’s science.

During two days of technical sessions, attendees will be provided with a high quality interaction with industry, academic, regulatory and clinical participants.

Secant Medical

Secant Medical designs and manufactures biomedical textiles and other structures for medical devices. Employing medical fabric engineering technologies, the company blends polymeric, metallic and resorbable biomaterials to create custom, high-performance structures that are used in the cardiovascular, general surgery, neurovascular, orthopedic and regenerative medicine fields.

The company is committed to the future of biomaterials and their role in the healing process and is actively engaged in research partnerships to advance next-generation biomaterial development.

www.secantmedical.com